Expression of Cytochromes P450 3A and P-Glycoprotein in Human Large Intestinse in Paired Tumour and Normal Samples
Roberto Canaparo
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Department of Anatomy, Pharmacology and Forensic Medicine, University of Torino, Torino, Italy,
Search for more papers by this authorAnna Nordmark
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorNiklas Finnström
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorStefan Lundgren
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorJaneric Seidegård
Discovery Medicine, AstraZeneca R&D, Lund, Sweden,
Search for more papers by this authorBengt Jeppsson
Department of Surgery, Malmö University Hospital, Malmö, Sweden, and
Search for more papers by this authorRobert J. Edwards
Experimental Medicine & Toxicology, Imperial College London, Hammersmith Campus, UK
Search for more papers by this authorAlan R. Boobis
Experimental Medicine & Toxicology, Imperial College London, Hammersmith Campus, UK
Search for more papers by this authorAnders Rane
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorRoberto Canaparo
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Department of Anatomy, Pharmacology and Forensic Medicine, University of Torino, Torino, Italy,
Search for more papers by this authorAnna Nordmark
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorNiklas Finnström
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorStefan Lundgren
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorJaneric Seidegård
Discovery Medicine, AstraZeneca R&D, Lund, Sweden,
Search for more papers by this authorBengt Jeppsson
Department of Surgery, Malmö University Hospital, Malmö, Sweden, and
Search for more papers by this authorRobert J. Edwards
Experimental Medicine & Toxicology, Imperial College London, Hammersmith Campus, UK
Search for more papers by this authorAlan R. Boobis
Experimental Medicine & Toxicology, Imperial College London, Hammersmith Campus, UK
Search for more papers by this authorAnders Rane
Department of Laboratory Medicine, Division of Clinical Pharmacology, Karolinska Institutet, Huddinge University Hospital, Stockholm, Sweden,
Search for more papers by this authorAbstract
Abstract: Our objective was to investigate the expression of different cytochromes P450 3A (CYP3A4, CYP3A5, and CYP3A7) and P-glycoprotein (ABCB1) genes along the human large intestine in paired tumour and normal samples. Real-time reverse transcriptase-polymerase chain reaction was used to measure CYP3A4-, CYP3A5-, CYP3A7- and ABCB1-specific mRNA expression, and Western blot analysis was used to measure membrane protein levels of CYP3A4/7, CYP3A5 and P-glycoprotein. Levels of mRNA and membrane protein fractions in the large intestine were compared with those of normal human liver. The mRNA expressions of CYP3A4, CYP3A5, CYP3A7 and ABCB1 in the large intestine were found to be highly variable, but overall the levels were significantly lower than those measured in liver (P < 0.0001, P < 0.001, P < 0.0001 and P < 0.01, respectively). At the membrane protein level, CYP3A4/7 was detected in all large intestine samples examined and the levels were substantially higher than those of the liver (P < 0.01). Although expression of CYP3A5 was detected in all large intestine samples, in most the levels were too low to allow quantification. P-glycoprotein was readily detected at levels slightly higher than those of liver (P < 0.05). Comparison between paired samples of normal and tumour in large intestine showed no significant differences in either the mRNA or membrane protein levels of these genes. In conclusion, this work suggests a potential role of the large intestine in the absorption and metabolism of xenobiotics and nutrients and no difference in the CYP3A and P-glycoprotein membrane protein fractions and mRNA expression between normal and tumour tissues.
References
- 1 Omura T. Forty years of cytochrome P450. Biochem Biophys Res Commun 1999; 266: 690–8.
- 2 De Wildt SN, Kearns GL, Leede JS, Van Den Anker JN. Cytochrome P450 3A: ontogeny and drug disposition. Clin Pharmacokinet 1999; 37: 485–505.
- 3 Gellner K, Eiselt R, Hustert E et al. Genomic organization of the human CYP3A locus: identification of a new, inducible CYP3A gene. Pharmacogenetics 2001; 11: 111–21.
- 4 Paine MF, Khalighi M, Fisher JM et al. Characterization of interintestinal and intraintestinal variations in human CYP3A-dependent metabolism. J Pharmacol Exp Ther 1997; 283: 1552–62.
- 5 Finnstrom N, Bjelfman C, Soderstrom TG et al. Detection of cytochrome P450 mRNA transcripts in prostate samples by RT-PCR. Eur J Clin Invest 2001; 31: 880–6.
- 6 Nishimura M, Yaguti H, Yoshitsugu H, Naito S, Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003; 123: 369–75.
- 7 Westlind-Johnsson A, Malmebo S, Johansson A et al. Comparative analysis of CYP3A expression in human liver suggests only a minor role for CYP3A5 in drug metabolism. Drug Metab Dispos 2003; 31: 755–61.
- 8 Von Richter O, Burk O, Fromm MF, Thon KP, Eichelbaum M, Kivisto KT. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens. Clin Pharmacol Ther 2004; 75: 172–83.
- 9 Yaffe SJ, Rane A, Sjoqvist F, Boreus LO, Orrenius S. The presence of a monooxygenase system in human fetal liver microsomes. Life Sci II 1970; 9: 1189–200.
- 10 Ladona MG, Lindstrom B, Thyr C, Dun-Ren P, Rane A. Differential foetal development of the O-and N-demethylation of codeine and dextromethorphan in man. Br J Clin Pharmacol 1991; 32: 295–302.
- 11 Ambudkar SV, Dey S, Hrycyna CA, Ramachandra M, Pastan I, Gottesman MM. Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu Rev Pharmacol Toxicol 1999; 39: 361–98.
- 12 De Silva MG, Kantharidis P, Scherer SW et al. Physical mapping of a tandem duplication on the long arm of chromosome 7 associated with a multidrug resistant phenotype. Cancer Genet Cytogenet 1999; 110: 28–33.
- 13 Frank TS. Hereditary cancer syndromes. Arch Pathol Lab Med 2001; 125: 85–90.
- 14 Lin JH, Chiba M, Baillie TA. Is the role of the small intestine in first-pass metabolism overemphasized? Pharmacol Rev 1999; 51: 135–58.
- 15 Zhang Y, Benet LZ. The gut as a barrier to drug absorption: combined role of cytochrome P450 3A and P-glycoprotein. Clin Pharmacokinet 2001; 40: 159–68.
- 16 Becquemont L, Camus M, Eschwege V et al. Lymphocyte P-glycoprotein expression and activity before and after rifampicin in man. Fundam Clin Pharmacol 2000; 14: 519–25.
- 17 Watkins PB. Drug metabolism by cytochromes P450 in the liver and small bowel. Gastroenterol Clin North Am 1992; 21: 511–26.
- 18 McKinnon RA, Burgess WM, Hall PM, Roberts-Thomson SJ, Gonzalez FJ, McManus ME. Characterisation of CYP3A gene subfamily expression in human gastrointestinal tissues. Gut 1995; 36: 259–67.
- 19 Thorn M, Finnstrom N, Lundgren S, Rane A, Loof L. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 2005; 60: 54–60.
- 20 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156–9.
- 21 Finnstrom N, Thorn M, Loof L, Rane A. Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. Eur J Clin Pharmacol 2001; 57: 403–9.
- 22 Bustin SA. Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays. J Mol Endocrinol 2000; 25: 169–93.
- 23 Von Bahr C, Groth CG, Jansson H, Lundgren G, Lind M, Glaumann H. Drug metabolism in human liver in vitro: establishment of a human liver bank. Clin Pharmacol Ther 1980; 27: 711–25.
- 24 Fasco MJ, Silkworth JB, Dunbar DA, Kaminsky LS. Rat small intestinal cytochromes P450 probed by warfarin metabolism. Mol Pharmacol 1993; 43: 226–33.
- 25 Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265–75.
- 26 Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76: 4350–4.
- 27 Edwards RJ, Adams DA, Watts PS, Davies DS, Boobis AR. Development of a comprehensive panel of antibodies against the major xenobiotic metabolising forms of cytochrome P450 in humans. Biochem Pharmacol 1998; 56: 377–87.
- 28 Fredericks WJ, Chen YF, Baker RM. Immunoblot detection of P-glycoprotein in human tumors and cell lines. Cancer Treat Res 1991; 57: 121–49.
- 29 Lacueva FJ, Teruel A, Calpena R et al. Detection of P-glycoprotein in frozen and paraffin-embedded gastric adenocarcinoma tissues using a panel of monoclonal antibodies. Histopathology 1998; 32: 328–34.
- 30 Thellin O, Zorzi W, Lakaye B et al. Housekeeping genes as internal standards: use and limits. J Biotechnol 1999; 75: 291–5.
- 31 Fakhoury M, Litalien C, Medard Y et al. Localization and mRNA expression of CYP3A and P-glycoprotein in human duodenum as a function of age. Drug Metab Dispos 2005; 33: 1603–7.
- 32 Aoyama T, Yamano S, Guzelian PS, Gelboin HV, Gonzalez FJ. Five of 12 forms of vaccinia virus-expressed human hepatic cytochrome P450 metabolically activate aflatoxin B1. Proc Natl Acad Sci USA 1990; 87: 4790–3.
- 33
Piipari R,
Savela K,
Nurminen T et al. Expression of CYP1A1, CYP1B1 and CYP3A, and polycyclic aromatic hydrocarbon-DNA adduct formation in bronchoalveolar macrophages of smokers and non-smokers.
Int J Cancer
2000; 86: 610–6.
10.1002/(SICI)1097-0215(20000601)86:5<610::AID-IJC2>3.0.CO;2-M CAS PubMed Web of Science® Google Scholar
- 34 Peters WH, Boon CE, Roelofs HM, Wobbes T, Nagengast FM, Kremers PG. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology 1992; 103: 448–55.
- 35 Caruso ML, Valentini AM, Armentano R, Pirrelli M. P-170 glycoprotein expression in gastric and colorectal carcinomas and normal mucosa. An immunocytochemical study. In Vivo 1995; 9: 133–8.
- 36 Fillpits M, Suchomel RW, Dekan G et al. Expression of the multidrug resistance-associated protein (MRP) gene in colorectal carcinomas. Br J Cancer 1997; 75: 208–12.
- 37 Nakamura T, Sakaeda T, Ohmoto N et al. Real-time quantitative polymerase chain reaction for MDR1, MRP1, MRP2, and CYP3A-mRNA levels in Caco-2 cell lines, human duodenal enterocytes, normal colorectal tissues, and colorectal adenocarcinomas. Drug Metab Dispos 2002; 30: 4–6.
- 38 Farrell RJ, Murphy A, Long A et al. High multidrug resistance (P-glycoprotein 170) expression in inflammatory bowel disease patients who fail medical therapy. Gastroenterology 2000; 118: 279–88.
- 39 Albertioni F, Gruber A, Arestrom I, Vitols S. Multidrug resistance gene (mdr1) RNA levels in relation to P-glycoprotein content of leukemic cells from patients with acute leukemia. Med Oncol 1995; 12: 79–86.
- 40 Kuehl P, Zhang J, Lin Y et al. Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat Genet 2001; 27: 383–91.
Citing Literature
